1 Result(s)

Article

Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated in clinical studies as a tumor cell selective pro-apoptotic approach. However, besides activating canonical ...

K Azijli, B Weyhenmeyer, G J Peters, S de Jong, F A E Kruyt in Cell Death & Differentiation (2013)